Mandy Lauw
@MandyNLauw
Followers
1K
Following
10K
Media
162
Statuses
3K
MD PhD,Hematologist @ErasmusMC @clotterdam🇳🇱 Bridging malignant/non-malignant #hematology. Thrombosis in (Heme) Malignancies. Former Chair of @Young_EHA
The Netherlands
Joined March 2017
#EHA2024 was a special #Congress! Presenting 2 lectures, but above all my last one as Chair of @young_eha🌱 Such a rewarding experience representing the #earlycareer community. Special thanks to #committee friends,@EHA_Hematology office & Board🙏🏼 #future of #hematology is bright!
5
4
49
RT @Hemasphere_EHA: We are HemaSphere proud at #EHA2025, where 2 of our editors received special EHA awards! Congrats to Jan Cools, Ed in C….
0
3
0
Very honored to receive the inaugural Young EHA #award today at the @EHA_Hematology #Congress in #Milan. A great acknowledgment for my time as Chair of the Young EHA committee and contributions to #earlycareer representation and opportunities in #hematology #EHA2025
2
3
33
0
3
0
RT @MiddeldorpS: Saying hi to our amazing @isth team #ASH24, and look what they had in store fore me! The must-have coagulation clock desig….
0
5
0
#bleeding remains the most important limitation in patients with #cancer, #thrombosis and #anticoagulation. @KSanfilippoMD has identified modifiable risk factors for bleeding that may improve outcomes #ASH24
0
1
11
Full room for #thrombosis & #hormones ; 5 key messages by @MiddeldorpS on role of #anticoagulation and #thrombophilia. Unfortunately due to planning competing sessions on classical #hematology by @ASH_hematology could not see contributions by @Clotmaster and @leslieskeith
2
4
14
RT @MarcCarrier1: Many anticoagulant-related bleedings 🩸 in patients with cancer are attributable to modifiable risk factors. Addressing th….
0
11
0
Proud of @joanhowMD and our GASTRO-MPN #collaboration presentation today at #ASH24; first results of management and outcomes of splanchnic vein #thrombosis in #MPN. Looking forward to our next steps! @ASH_hematology @isth
1
5
22
RT @MiddeldorpS: Large multi-national cohort study of pts with MPN and splanchnic vein thrombosis shows high risk of recurrent thrombosis a….
0
4
0
RT @CardioNowNews: Rivaroxaban for 18 Months Superior to 6 Months To Prevent Recurrent VTE Events in Cancer Patients with Acute-low PE: ONC….
cardiologynownews.org
Key Takeaways: The ONCO PE trial demonstrated that an 18-month treatment with rivaroxaban significantly reduced…
0
4
0
RT @DelwelRuud: Erasmus MC virtual Hematology lecture .November 4th, 16.00 CET!.We have:. Job Dekker, University of Massachusetts, Worceste….
0
9
0
RT @FaizanK91: 🆕🚨Whether patients taking #DOACs should receive thrombolysis for ischemic stroke is uncertain‼️ Coinciding with #WSC2024, ou….
0
38
0
RT @young_eha: First joint @young_eha session at #Serbian national #hematology meeting! Engaging with local #earlycareer hematologists and….
0
7
0
0
4
10
Joint #infection session of @EHA_Hematology @EHAInfectionsH1 and #Serbian national hematology society meeting with presentation of @SalmantonGarcia on #fungal prophylaxis and treatment in hematologic malignancies #hematology #Belgrade @young_eha
1
3
7
RT @NicoGagelmann: The floor is prepared thanks to both @EHA_Hematology and @dgho_eV. Trainees, residents, students from 🇨🇭🇦🇹🇩🇪! Join th….
0
3
0
RT @MiddeldorpS: Personalized medicine getting closer: Impact of the VTE-PREDICT calculator on clinicians’ decision making in fictional pat….
rpthjournal.org
After 3 months of anticoagulation for venous thromboembolism (VTE), the decision needs to be made whether to stop anticoagulation or extend treatment indefinitely. The VTE-PREDICT calculator can be...
0
7
0
RT @bbikdeli: 🚨Interactions between #food 🥘🍲/🌿& oral #anticoagulants: There's plenty for #warfarin, but few important ones for #DOACs, too!….
0
23
0
RT @young_eha: #Burnout is a major issue among healthcare professionals and #hematology is no different but hard evidence is lacking. Compl….
0
13
0
RT @DrRaulCordoba: #CRTH2024 has come to its end. Amazing scholars, high expertise faculty, extraordinary organization. Thanks to @EHA_Hema….
0
5
0